Captrust Financial Advisors Has $634,000 Stake in Oscar Health, Inc. (NYSE:OSCR)

Captrust Financial Advisors decreased its position in Oscar Health, Inc. (NYSE:OSCR) by 1.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 47,176 shares of the company’s stock after selling 791 shares during the period. Captrust Financial Advisors’ holdings in Oscar Health were worth $634,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Lingotto Investment Management LLP acquired a new stake in shares of Oscar Health in the 4th quarter valued at about $2,543,000. GDS Wealth Management grew its holdings in shares of Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock valued at $4,648,000 after acquiring an additional 324,798 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Oscar Health by 296.0% in the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company’s stock valued at $3,105,000 after acquiring an additional 172,706 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Oscar Health in the 4th quarter valued at about $5,672,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Oscar Health by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,862 shares of the company’s stock valued at $22,241,000 after acquiring an additional 54,696 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Buying and Selling

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 24.39% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Separately, Wells Fargo & Company cut Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and an average price target of $20.08.

Oscar Health Trading Up 5.8%

Oscar Health stock opened at $17.52 on Friday. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $4.39 billion, a P/E ratio of -875.31 and a beta of 1.75. The stock has a 50-day simple moving average of $13.46 and a 200 day simple moving average of $14.65.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business had revenue of $3 billion during the quarter, compared to analysts’ expectations of $2.87 billion. During the same quarter last year, the company posted $0.62 earnings per share. Oscar Health’s quarterly revenue was up 42.2% on a year-over-year basis. Analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.